Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pluvicto
Pharma
Novartis builds momentum with new drug launches
Novartis CEO Vas Narasimhan acknowledged that the company could have made its recent $23 billion U.S. investment plan sooner.
Angus Liu
Apr 29, 2025 10:52am
Novartis' Pluvicto wins key FDA nod toward $5B-plus sales target
Mar 28, 2025 3:02pm
Novartis' Pluvicto topples AbbVie's Skyrizi in TV spending ranks
Feb 5, 2025 1:49pm
Novartis filed patent lawsuits in defense of radiopharma meds
Nov 4, 2024 10:48am
Novartis complies with FDA 'flexibility' ask in Pluvicto filing
Oct 29, 2024 10:51am
Novartis brings isotope production in house amid global shortage
Sep 4, 2024 11:24am
.jpg?VersionId=VoHpLW2C1Jv3f5hTX2MDM.CmZ4_BwGWi)
